Two chemical protocols for the rapid analysis of protein phosphorylation by mass spectrometry promise to expand the scope of proteomics research.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
CSNK2 in cancer: pathophysiology and translational applications
British Journal of Cancer Open Access 12 November 2021
-
A novel mass spectrometry-based assay for GSK-3β activity
BMC Biochemistry Open Access 16 December 2005
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Zhou, H., Watts, J.D. & Aebersold, R. Nat. Biotechnol. 19, 375–378 (2001).
Oda, Y., Nagasu, T. & Chait, B.T. Nat. Biotechnol. 19, 379–382 (2001).
Andersson, L. & Porath, J. Anal. Biochem. 154, 250–254 (1986).
Byford, M.F. Biochem. J. 280, 261–265 (1991).
Link A.J et al. Nat. Biotechnol. 17, 676–682 (1999).
Washburn, M.P., Wolters, D., & Yates, J.R. Nat. Biotechnol. 19, 242–247 (2001).
Gygi, S.P. et al. Nat. Biotechnol. 17, 994–999 (1999).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ahn, N., Resing, K. Toward the phosphoproteome. Nat Biotechnol 19, 317–318 (2001). https://doi.org/10.1038/86687
Issue Date:
DOI: https://doi.org/10.1038/86687
This article is cited by
-
CSNK2 in cancer: pathophysiology and translational applications
British Journal of Cancer (2022)
-
A novel mass spectrometry-based assay for GSK-3β activity
BMC Biochemistry (2005)
-
Monitoring post-translational modification of proteins with allosteric ribozymes
Nature Biotechnology (2002)